These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Cannabimimetic effects of abused indazole-carboxamide synthetic cannabinoid receptor agonists AB-PINACA, 5F-AB-PINACA and 5F-ADB-PINACA in mice: Tolerance, dependence and withdrawal. Wilson CD; Hiranita T; Fantegrossi WE Drug Alcohol Depend; 2022 Jul; 236():109468. PubMed ID: 35643039 [TBL] [Abstract][Full Text] [Related]
4. Systematic evaluation of a panel of 30 synthetic cannabinoid receptor agonists structurally related to MMB-4en-PICA, MDMB-4en-PINACA, ADB-4en-PINACA, and MMB-4CN-BUTINACA using a combination of binding and different CB Grafinger KE; Cannaert A; Ametovski A; Sparkes E; Cairns E; Banister SD; Auwärter V; Stove CP Drug Test Anal; 2021 Jul; 13(7):1402-1411. PubMed ID: 33769699 [TBL] [Abstract][Full Text] [Related]
5. Systematic evaluation of a panel of 30 synthetic cannabinoid receptor agonists structurally related to MMB-4en-PICA, MDMB-4en-PINACA, ADB-4en-PINACA, and MMB-4CN-BUTINACA using a combination of binding and different CB Pike E; Grafinger KE; Cannaert A; Ametovski A; Luo JL; Sparkes E; Cairns EA; Ellison R; Gerona R; Stove CP; Auwärter V; Banister SD Drug Test Anal; 2021 Jul; 13(7):1383-1401. PubMed ID: 33787091 [TBL] [Abstract][Full Text] [Related]
6. Convulsant doses of abused synthetic cannabinoid receptor agonists AB-PINACA, 5F-AB-PINACA, 5F-ADB-PINACA and JWH-018 do not elicit electroencephalographic (EEG) seizures in male mice. Wilson CD; Zheng F; Fantegrossi WE Psychopharmacology (Berl); 2022 Oct; 239(10):3237-3248. PubMed ID: 35933518 [TBL] [Abstract][Full Text] [Related]
7. In vitro cannabinoid activity profiling of generic ban-evading brominated synthetic cannabinoid receptor agonists and their analogs. Deventer MH; Persson M; Norman C; Liu H; Connolly MJ; Daéid NN; McKenzie C; Gréen H; Stove CP Drug Test Anal; 2024 Jun; 16(6):616-628. PubMed ID: 37903509 [TBL] [Abstract][Full Text] [Related]
8. The metabolism of the synthetic cannabinoids ADB-BUTINACA and ADB-4en-PINACA and their detection in forensic toxicology casework and infused papers seized in prisons. Kronstrand R; Norman C; Vikingsson S; Biemans A; Valencia Crespo B; Edwards D; Fletcher D; Gilbert N; Persson M; Reid R; Semenova O; Al Teneiji F; Wu X; Dahlén J; NicDaéid N; Tarbah F; Sutcliffe OB; McKenzie C; Gréen H Drug Test Anal; 2022 Apr; 14(4):634-652. PubMed ID: 34811926 [TBL] [Abstract][Full Text] [Related]
9. Systematic evaluation of a panel of 30 synthetic cannabinoid receptor agonists structurally related to MMB-4en-PICA, MDMB-4en-PINACA, ADB-4en-PINACA, and MMB-4CN-BUTINACA using a combination of binding and different CB1 receptor activation assays. Part III: The G protein pathway and critical comparison of different assays. Grafinger KE; Vandeputte MM; Cannaert A; Ametovski A; Sparkes E; Cairns E; Juchli PO; Haschimi B; Pulver B; Banister SD; Stove CP; Auwärter V Drug Test Anal; 2021 Jul; 13(7):1412-1429. PubMed ID: 33908179 [TBL] [Abstract][Full Text] [Related]
10. A new cannabinoid receptor 1 selective agonist evading the 2021 "China ban": ADB-FUBIATA. Deventer MH; Van Uytfanghe K; Vinckier IMJ; Reniero F; Guillou C; Stove CP Drug Test Anal; 2022 Sep; 14(9):1639-1644. PubMed ID: 35570246 [TBL] [Abstract][Full Text] [Related]
11. Involuntary MDMB-4en-PINACA intoxications following cannabis consumption: clinical and analytical findings. Goncalves R; Labadie M; Chouraqui S; Peyré A; Castaing N; Daveluy A; Molimard M Clin Toxicol (Phila); 2022 Apr; 60(4):458-463. PubMed ID: 34850659 [TBL] [Abstract][Full Text] [Related]
12. In vitro and in vivo pharmacology of nine novel synthetic cannabinoid receptor agonists. Marusich JA; Gamage TF; Zhang Y; Akinfiresoye LR; Wiley JL Pharmacol Biochem Behav; 2022 Oct; 220():173467. PubMed ID: 36154844 [TBL] [Abstract][Full Text] [Related]
14. In vitro metabolism study of ADB-P-5Br-INACA and ADB-4en-P-5Br-INACA using human hepatocytes, liver microsomes, and in-house synthesized references. Rautio T; Obrist R; Krebs L; Klingstedt T; Dahlén J; Wu X; Gréen H Drug Test Anal; 2024 Jul; ():. PubMed ID: 39039949 [TBL] [Abstract][Full Text] [Related]
15. Differential cannabinoid-like effects and pharmacokinetics of ADB-BICA, ADB-BINACA, ADB-4en-PINACA and MDMB-4en-PINACA in mice: A comparative study. Zhou F; Wang X; Tan S; Shi Y; Xie B; Xiang P; Cong B; Ma C; Wen D Addict Biol; 2024 Feb; 29(2):e13372. PubMed ID: 38380735 [TBL] [Abstract][Full Text] [Related]
16. Detection and quantitation of synthetic cannabinoid receptor agonists in infused papers from prisons in a constantly evolving illicit market. Norman C; Walker G; McKirdy B; McDonald C; Fletcher D; Antonides LH; Sutcliffe OB; Nic Daéid N; McKenzie C Drug Test Anal; 2020 Apr; 12(4):538-554. PubMed ID: 31944624 [TBL] [Abstract][Full Text] [Related]
17. In vitro characterization of the pyrazole-carrying synthetic cannabinoid receptor agonist 5F-3,5-AB-PFUPPYCA and its structural analogs. Deventer MH; Norman C; Reid R; McKenzie C; Nic Daéid N; Stove CP Forensic Sci Int; 2023 Feb; 343():111565. PubMed ID: 36640535 [TBL] [Abstract][Full Text] [Related]
18. Relationships between preclinical cardiac electrophysiology, clinical QT interval prolongation and torsade de pointes for a broad range of drugs: evidence for a provisional safety margin in drug development. Redfern WS; Carlsson L; Davis AS; Lynch WG; MacKenzie I; Palethorpe S; Siegl PK; Strang I; Sullivan AT; Wallis R; Camm AJ; Hammond TG Cardiovasc Res; 2003 Apr; 58(1):32-45. PubMed ID: 12667944 [TBL] [Abstract][Full Text] [Related]
19. Cannabis adulterated with the synthetic cannabinoid receptor agonist MDMB-4en-PINACA and the role of European drug checking services. Oomen PE; Schori D; Tögel-Lins K; Acreman D; Chenorhokian S; Luf A; Karden A; Paulos C; Fornero E; Gerace E; Koning RPJ; Galindo L; Smit-Rigter LA; Measham F; Ventura M Int J Drug Policy; 2022 Feb; 100():103493. PubMed ID: 34687992 [TBL] [Abstract][Full Text] [Related]
20. Metabolic profiles and screening tactics for MDMB-4en-PINACA in human urine and serum samples. Gu K; Qin S; Zhang Y; Zhang W; Xin G; Shi B; Wang J; Wang Y; Lu J J Pharm Biomed Anal; 2022 Oct; 220():114985. PubMed ID: 35985137 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]